Labcorp Lays out Priorities and Progress in Corporate Responsibility Report
March 25 2021 - 6:59AM
Business Wire
Company Focuses on Sustainable Environmental,
Health and Safety Performance, and Advancing Diversity and
Inclusion
Labcorp (NYSE: LH), a leading global life sciences company,
today issued its 2019-2020 Corporate Responsibility Report: Making
a Difference When It Counts. The report includes the ways in which
Labcorp carries out its mission of improving health and improving
lives, and charts its progress on priorities including the
company’s environmental, health, and safety performance, as well as
its community partnerships and its commitments to advancing
diversity and inclusion.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210325005453/en/
Photo courtesy of Labcorp
Highlights from 2019-2020 include:
- Mobilizing vast parts of the company’s more than 70,000
employees to fight COVID-19 and provide support for the response to
the pandemic, including developing innovative COVID-19 tests and
delivering these tests to tens of millions of patients, and
performing vital research on new vaccines and therapeutics.
- Conducting more than $1 billion worth of transactions annually
with small businesses owned by minorities, women, veterans, and
economically disadvantaged groups.
- Advancing the company’s commitment to sustainability, including
reducing carbon emissions, increasing recycling, and making
facilities more energy efficient.
- Creating a more diverse and inclusive workforce, establishing
employee resource groups at sites around the world, and improving
employee health and wellness.
- Investing in the communities in which Labcorp operates,
including supporting educational initiatives such as a $1 million
donation to Alamance Community College in North Carolina, enhancing
diabetes education among at-risk communities in Canada, and helping
to provide a clean and reliable water supply to several communities
in India.
“I’m incredibly proud of the tireless work our employees have
done, especially over this past year, to deliver science-based
innovation and timely, trusted information to everyone from doctors
and drug developers to governments and patients,” said Adam
Schechter, chairman and CEO, Labcorp. “We made tremendous progress
on our priorities around sustainable environmental, health and
safety performance, as well as our community partnerships and
commitments to advancing diversity and inclusion. We are committed
to serving all of our stakeholders with ethics and integrity as we
build on the progress outlined in this year’s Corporate
Responsibility Report and come together to meet the challenges
ahead and build a better tomorrow.”
About Labcorp
Labcorp is a leading global life sciences company that provides
vital information to help doctors, hospitals, pharmaceutical
companies, researchers, and patients make clear and confident
decisions. Through our unparalleled diagnostics and drug
development capabilities, we provide insights and accelerate
innovations to improve health and improve lives. With more than
70,000 employees, we serve clients in more than 100 countries.
Labcorp (NYSE: LH) reported revenue of $14 billion in FY2020. Learn
more about us at www.Labcorp.com or follow us on LinkedIn and
Twitter @Labcorp.
Cautionary Statement Regarding Forward-Looking
Statements
This press release contains forward-looking statements,
including but not limited to statements with respect to recognition
and reputation of the Company. Each of the forward-looking
statements is subject to change based on various important factors,
many of which are beyond the Company’s control, including without
limitation, the COVID-19 pandemic and its impact on our business
and financial condition as well as general economic, business, and
market conditions, competitive actions and other unforeseen changes
and general uncertainties in the marketplace, changes in government
regulations, including healthcare reform, customer purchasing
decisions, including changes in payer regulations or policies,
other adverse actions of governmental and third-party payers,
changes in testing guidelines or recommendations, federal, state,
and local governmental responses to the COVID-19 pandemic, the
effect of public opinion on the Company’s reputation, adverse
results in material litigation matters, failure to maintain or
develop customer relationships, our ability to develop or acquire
new products and adapt to technological changes, failure in
information technology, systems or data security, the number of
revenue days in a financial period, personnel costs, and the effect
of exchange rate fluctuations, and employee relations. These
factors, in some cases, have affected and in the future (together
with other factors) could affect the Company’s ability to implement
the Company’s business strategy and actual results could differ
materially from those suggested by these forward-looking
statements. As a result, readers are cautioned not to place undue
reliance on any of our forward-looking statements. The Company has
no obligation to provide any updates to these forward-looking
statements even if its expectations change. All forward-looking
statements are expressly qualified in their entirety by this
cautionary statement. Further information on potential factors,
risks and uncertainties that could affect operating and financial
results is included in the Company’s most recent Annual Report on
Form 10-K and subsequent Forms 10-Q, including in each case under
the heading RISK FACTORS, and in the Company’s other filings with
the SEC.
###
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210325005453/en/
Labcorp Contacts: Media: Christopher Allman-Bradshaw —
336-436-8263 Media@Labcorp.com
Investors: Chas Cook --
336-436-5076 Investor@Labcorp.com
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Apr 2023 to Apr 2024